Michael-John Devlin
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Ovarian cancer diagnosis and treatment 6
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- PARP inhibition in cancer therapy 2
- Lung Cancer Research Studies 1
- Co-authors
- Martin David Forster (1 shared paper)Thomas R. Jeffry Evans (1 shared paper)José María López-Picazo (1 shared paper)Suzanne Louise Topalian (1 shared paper)Ibrahima Soumaoro (1 shared paper)Junchen Gu (1 shared paper)Tim Meyer (1 shared paper)Robert Wendel Naumann (1 shared paper)
- Journals
- International Journal of Gynecological Cancer (2 papers)Therapeutic Advances in Medical Oncology (1 paper)Journal of Clinical Oncology (1 paper)JAMA Oncology (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Michael-John Devlin
9 papers receiving 577 citations
Michael-John Devlin's Hit Papers
Peers
Comparison fields: 5 of 43
- Obstetrics and Gynecology 155
- Reproductive Medicine 110
- Oncology 256
- Immunology 113
- Otorhinolaryngology 20
Countries citing papers authored by Michael-John Devlin
This map shows the geographic impact of Michael-John Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael-John Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael-John Devlin more than expected).
Fields of papers citing papers by Michael-John Devlin
This network shows the impact of papers produced by Michael-John Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael-John Devlin. The network helps show where Michael-John Devlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael-John Devlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial Hit paper breakdown → | 2019 | 353 |
| 2 | 2018 | 97 | |
| 3 | 2019 | 87 | |
| 4 | 2022 | 27 | |
| 5 | 2025 | 17 | |
| 6 | 2022 | 2 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2018 | 0 |
About Michael-John Devlin
Michael-John Devlin is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Cancer Research and Pathology and Forensic Medicine, having authored 10 papers that have together received 587 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Cancer Immunotherapy and Biomarkers (2 papers), PARP inhibition in cancer therapy (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), CRISPR and Genetic Engineering (1 paper), Cancer Genomics and Diagnostics (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Obstetrics and Gynecology (155 citations), Reproductive Medicine (110 citations), Oncology (256 citations), Immunology (113 citations) and Otorhinolaryngology (20 citations). Michael-John Devlin has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Martin David Forster, Thomas R. Jeffry Evans, José María López-Picazo, Suzanne Louise Topalian, Ibrahima Soumaoro, Junchen Gu, Tim Meyer, Robert Wendel Naumann, Joseph N. Kerger and Antoine Hollebecque. Their work appears in journals such as International Journal of Gynecological Cancer, Therapeutic Advances in Medical Oncology, Journal of Clinical Oncology, JAMA Oncology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.